Evaluation of fiberoptic dermofluorometry as a means of clinically assessing tissue perfusion.
Fiberoptic dermofluorometry (FDF) transcutaneously measures fluorescence, following an intravenous injection of sodium fluorescein (NaFl), which is transmitted along a fiberoptic bundle to a photomultiplier tube and converted into dermofluorescence units (DFU). In five normal subjects studied, the plasma concentration of NaFl peaked at 5-15 minutes before decaying with first order kinetics and corresponding dermofluorescence (DF) rose to a peak between 10-20 minutes before decaying. Peak DF in the head and neck was significantly higher (P less than .001) compared to other skin sites which were similar. Application to patients (n = 16) undergoing successful lower limb revascularization showed a significant (P less than 0.01) improvement in perfusion at the foot level only. The reproducibility of FDF was poor when studied on the control limbs. We conclude that FDF does not, at present, constitute a valid measure of skin perfusion.
D000328:Adult; D000368:Aged; D001775:Blood Circulation; D005260:Female; D005336:Fiber Optic Technology; D005470:Fluorometry; D006801:Humans; D007866:Leg; D008297:Male; D008875:Middle Aged; D012879:Skin Physiological Phenomena; D014652:Vascular Diseases / Q000503:physiopathology*